Pediatric Covid Protections Limited by the Medical Police State Volume 4 - Issue 4

Paul Kempen*

• Weirton Medical Center, Weirton, West Virginia, USA

Received:August 27, 2021;  Published: September 14, 2021

Corresponding author: Paul Kempen, Weirton Medical Center, Weirton, West Virginia, USA

DOI: 10.32474/GJAPM.2021.04.000196

Fulltext PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

On Monday, August 23, 2021, the Food and Drug Administration (FDA) approved Pfizer’s covid vaccine for general use. The legal reality is, that after general release of any drug by the FDA and under normal circumstances, this would allow physicians to prescribe and utilize the drug in Americans of any age, including children. We know CDC data documents hundreds of thousands of childhood covid cases and hundreds of deaths with rising numbers, while hopefully children are returning to school exposed to increasing risks. Although Federal laws prohibit age and disability discrimination, children and especially “at risk” children < 12 years are not being fully offered any of the treatments authorized under the emergency use authority (EUA) to mitigate the covid scourge. The Pfizer vaccine was released yesterday for Americans 12 years of age and >40 KG. In 2002, the Association of American Physicians and Surgeons sued in Federal Courts, which determined the “FDA Does Not Have The Authority to Require Pediatric Testing of Drugs”. This ruling allows all approved drugs to be used in children as “off label”, when appropriately prescribed and especially with informed consent [1].

Opinion| References|